Experts to call for drug reclassification in promotion of OTC drugs.

Experts said that the non-prescription drug markets could be activated by reclassifying the prescription and non-prescription drugs instead of the current fixed rate system, which is implemented from this month.

Mr. Chung Myeong-jin, the chief of the industry analysis and statistic team of the Korea Health Industry Development Institute (KHIDI) said about the relation between the implementat...